Notice: This company has been marked as potentially delisted and may not be actively trading. Lionheart Acquisition Co. II (LCAP) Competitors Add Compare Share Share Competitors Stock AnalysisCompetitorsTrends LCAP vs. DNMR, RANI, DERM, VXRT, INMB, INO, SCLX, IPSC, AKYA, and FONRShould you be buying Lionheart Acquisition Co. II stock or one of its competitors? The main competitors of Lionheart Acquisition Co. II include Danimer Scientific (DNMR), Rani Therapeutics (RANI), Journey Medical (DERM), Vaxart (VXRT), INmune Bio (INMB), Inovio Pharmaceuticals (INO), Scilex (SCLX), Century Therapeutics (IPSC), Akoya Biosciences (AKYA), and FONAR (FONR). Lionheart Acquisition Co. II vs. Danimer Scientific Rani Therapeutics Journey Medical Vaxart INmune Bio Inovio Pharmaceuticals Scilex Century Therapeutics Akoya Biosciences FONAR Lionheart Acquisition Co. II (NASDAQ:LCAP) and Danimer Scientific (NYSE:DNMR) are both small-cap medical companies, but which is the superior business? We will contrast the two companies based on the strength of their earnings, profitability, community ranking, media sentiment, valuation, institutional ownership, analyst recommendations, risk and dividends. Which has higher earnings and valuation, LCAP or DNMR? Lionheart Acquisition Co. II has higher earnings, but lower revenue than Danimer Scientific. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioLionheart Acquisition Co. IIN/AN/A$3.21MN/AN/ADanimer Scientific$46.68M0.32-$155.47M-$33.78-0.15 Do analysts rate LCAP or DNMR? Danimer Scientific has a consensus target price of $13.83, indicating a potential upside of 175.71%. Given Danimer Scientific's stronger consensus rating and higher possible upside, analysts clearly believe Danimer Scientific is more favorable than Lionheart Acquisition Co. II.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Lionheart Acquisition Co. II 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00Danimer Scientific 1 Sell rating(s) 2 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.67 Do insiders and institutionals have more ownership in LCAP or DNMR? 33.8% of Danimer Scientific shares are held by institutional investors. 19.4% of Lionheart Acquisition Co. II shares are held by insiders. Comparatively, 16.6% of Danimer Scientific shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term. Which has more risk & volatility, LCAP or DNMR? Lionheart Acquisition Co. II has a beta of 0.08, suggesting that its share price is 92% less volatile than the S&P 500. Comparatively, Danimer Scientific has a beta of 1.63, suggesting that its share price is 63% more volatile than the S&P 500. Does the MarketBeat Community favor LCAP or DNMR? Danimer Scientific received 9 more outperform votes than Lionheart Acquisition Co. II when rated by MarketBeat users. CompanyUnderperformOutperformLionheart Acquisition Co. IIN/AN/ADanimer ScientificOutperform Votes932.14% Underperform Votes1967.86% Is LCAP or DNMR more profitable? Lionheart Acquisition Co. II has a net margin of 0.00% compared to Danimer Scientific's net margin of -297.10%. Lionheart Acquisition Co. II's return on equity of -44.30% beat Danimer Scientific's return on equity.Company Net Margins Return on Equity Return on Assets Lionheart Acquisition Co. IIN/A -44.30% 1.39% Danimer Scientific -297.10%-45.78%-17.12% Does the media favor LCAP or DNMR? In the previous week, Danimer Scientific had 15 more articles in the media than Lionheart Acquisition Co. II. MarketBeat recorded 15 mentions for Danimer Scientific and 0 mentions for Lionheart Acquisition Co. II. Lionheart Acquisition Co. II's average media sentiment score of 0.00 beat Danimer Scientific's score of -0.11 indicating that Lionheart Acquisition Co. II is being referred to more favorably in the media. Company Overall Sentiment Lionheart Acquisition Co. II Neutral Danimer Scientific Neutral SummaryDanimer Scientific beats Lionheart Acquisition Co. II on 7 of the 13 factors compared between the two stocks. Ad Colonial MetalsTrump’s IRS Hands Massive ‘Victory Gift’ To 401K OwnersThe "Fake Media" has completely ignored Trump's genius "victory gift" to all America First patriots like you. A tax-free gift so powerful it could reshape the financial destinies of millions of IRA and 401(k) owners…Claim your FREE 2024 Gold Guide Get Lionheart Acquisition Co. II News Delivered to You Automatically Sign up to receive the latest news and ratings for LCAP and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart LCAP vs. The Competition Export to ExcelMetricLionheart Acquisition Co. IIBusiness Services IndustryMedical SectorNASDAQ ExchangeMarket Cap$27.31M$1.17B$5.14B$8.84BDividend YieldN/A4.87%5.05%4.07%P/E RatioN/A797.84125.0517.04Price / SalesN/A138.371,232.2287.12Price / Cash20.6422.9439.9936.27Price / Book-0.522.836.956.36Net Income$3.21M-$5.18M$119.41M$226.00M Lionheart Acquisition Co. II Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)LCAPLionheart Acquisition Co. IIN/A$1.48-8.1%N/A-74.6%$27.31MN/A0.003DNMRDanimer Scientific1.2175 of 5 stars$5.02-12.1%$13.83+175.7%-85.2%$15.05M$46.68M-0.15257Analyst DowngradeNews CoverageHigh Trading VolumeRANIRani Therapeutics3.1743 of 5 stars$2.03-1.0%$11.71+477.1%+2.5%$108.42M$2.72M-1.92110Analyst ForecastDERMJourney Medical3.242 of 5 stars$5.20-0.6%$9.38+80.3%N/A$107.80M$79.18M-5.5690Analyst RevisionNews CoverageVXRTVaxart2.2093 of 5 stars$0.60-1.6%$3.00+400.6%-22.1%$106.33M$7.38M-1.46109Analyst RevisionNews CoveragePositive NewsINMBINmune Bio2.1388 of 5 stars$4.78+4.8%$20.00+318.4%-39.1%$105.97M$160,000.00-2.0910INOInovio Pharmaceuticals3.3847 of 5 stars$4.06+2.3%$38.00+836.0%-93.4%$105.97M$830,000.000.00127Analyst ForecastAnalyst RevisionSCLXScilex3.4645 of 5 stars$0.55-1.8%$11.33+1,955.0%-48.7%$105.77M$46.74M-0.3980Gap UpIPSCCentury Therapeutics1.5883 of 5 stars$1.24-1.6%$11.60+835.5%-11.9%$105.44M$2.23M-0.67170AKYAAkoya Biosciences1.7177 of 5 stars$2.11-2.3%$5.43+157.3%-50.8%$104.57M$96.63M-1.7990Analyst ForecastFONRFONAR1.9274 of 5 stars$16.45+10.5%N/A-18.3%$104.13M$102.88M11.75480High Trading Volume Related Companies and Tools Related Companies DNMR Alternatives RANI Alternatives DERM Alternatives VXRT Alternatives INMB Alternatives INO Alternatives SCLX Alternatives IPSC Alternatives AKYA Alternatives FONR Alternatives Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:LCAP) was last updated on 11/21/2024 by MarketBeat.com Staff From Our PartnersThe Crypto That’s Making Wall Street SweatThe Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech gian...Crypto 101 Media | SponsoredMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredThe pin that pops the AI bubbleMy new documentary explores the background to this pattern and how and why I believe it will almost certainly ...Porter & Company | SponsoredCrypto’s next big bull run?Juan Villaverde may be America’s top crypto expert. And he says something big is coming for crypto – on Nov...Weiss Ratings | Sponsored“This Changes Everything” - Trump Hands Millions Massive IRS GiftNow it's your time to return the favor by taking advantage of this tax "revenge loophole." Because even as ...Colonial Metals | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Lionheart Acquisition Co. II Please log in to your account or sign up in order to add this asset to your watchlist. Share Lionheart Acquisition Co. II With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free LCAP Stock Alerts